Vanguard FTSE Developed Europe ex UK UCITS ETF Distributing (GBP) | VERXRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.6 | 24.9 | -12.7 | 18.1 | 4.6 | |
+/-Cat | -6.8 | 9.5 | -4.0 | 4.6 | 0.0 | |
+/-B’mrk | -5.3 | 7.7 | -5.3 | 3.1 | -0.2 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
Closing Price 31/05/2024 | GBX 3516.50 | |
Day Change | 0.52% | |
Morningstar Category™ | Europe ex-UK Equity | |
Volume | 57336 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BKX55S42 | |
Fund Size (Mil) 31/05/2024 | EUR 2672.56 | |
Share Class Size (Mil) 31/05/2024 | EUR 2160.55 | |
Ongoing Charge 17/02/2023 | 0.10% |
Investment Objective: Vanguard FTSE Developed Europe ex UK UCITS ETF Distributing (GBP) | VERX |
This Fund seeks to track the performance of the Index, a widely recognised market- capitalization weighted index of stock market performance of European developed countries, excluding the United Kingdom, that is comprised of the stocks of large and mid capitalisation companies in that region. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 30/09/2014 | ||
Inception Date 30/09/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE Developed Europe ex UK NR EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Vanguard FTSE Developed Europe ex UK UCITS ETF Distributing (GBP) | VERX | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 4.77 |
ASML Holding NV | Technology | 4.18 |
Nestle SA | Consumer Defensive | 3.20 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 2.44 |
Novartis AG Registered Shares | Healthcare | 2.39 |
Increase Decrease New since last portfolio | ||
Vanguard FTSE Developed Europe ex UK UCITS ETF Distributing (GBP) | VERX |